期刊名：Antibodies

期刊主页：https://www.mdpi.com/journal/antibodies

本期编辑荐读为您精选2024年发表于 Antibodies 期刊的十篇高引review。希望能为相关领域学者提供新的思路和参考，欢迎阅读。

1. Diagnosis and Management of Catastrophic Antiphospholipid Syndrome and the Potential Impact of the 2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria

灾难性抗磷脂综合征的诊断与管理及 2023 年 ACR/EULAR 抗磷脂综合征分类标准的潜在影响

http://www.mdpi.com/2073-4468/13/1/21

Jacobs, L.; Wauters, N.; Lablad, Y.; Morelle, J.; Taghavi, M. Diagnosis and Management of Catastrophic Antiphospholipid Syndrome and the Potential Impact of the 2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria. Antibodies 2024, 13, 21.

2. Myelin Oligodendrocyte Glycoprotein-Antibody Associated Disease: An Updated Review of the Clinical Spectrum, Pathogenetic Mechanisms and Therapeutic Management

髓鞘少突胶质细胞糖蛋白抗体相关疾病：临床表现、发病机制和治疗管理的最新综述

http://www.mdpi.com/2073-4468/13/2/43

Gklinos, P.; Dobson, R. Myelin Oligodendrocyte Glycoprotein-Antibody Associated Disease: An Updated Review of the Clinical Spectrum, Pathogenetic Mechanisms and Therapeutic Management. Antibodies 2024, 13, 43.

3. Unveiling GFAP Astrocytopathy: Insights from Case Studies and a Comprehensive Review of the Literature

揭示GFAP星形胶质细胞病：病例研究的启示和文献综述

http://www.mdpi.com/2073-4468/13/4/79

Gklinos, P.; Athanasopoulos, F.; Giatrakou, V.; Arkoudis, N.-A.; Pournara, D.; Giagkou, E.; Tountopoulou, A.; Vassilopoulou, S.; Mitsikostas, D.-D. Unveiling GFAP Astrocytopathy: Insights from Case Studies and a Comprehensive Review of the Literature. Antibodies 2024, 13, 79.

4. Antiphospholipid Antibodies Associated with Native Arteriovenous Fistula Complications in Hemodialysis Patients: A Comprehensive Review of the Literature

抗磷脂抗体与血液透析患者天然动静脉瘘并发症的关系：文献综述

http://www.mdpi.com/2073-4468/13/1/1

Taghavi, M.; Jabrane, A.; Jacobs, L.; Mesquita, M.D.C.F.; Demulder, A.; Nortier, J. Antiphospholipid Antibodies Associated with Native Arteriovenous Fistula Complications in Hemodialysis Patients: A Comprehensive Review of the Literature. Antibodies 2024, 13, 1.

5. A Narrative Review of the State of the Art of CCR4-Based Therapies in Cutaneous T-Cell Lymphomas: Focus on Mogamulizumab and Future Treatments

皮肤T细胞淋巴瘤CCR4靶向治疗现状综述：聚焦莫加莫利珠单抗及未来治疗

http://www.mdpi.com/2073-4468/13/2/32

Zengarini, C.; Guglielmo, A.; Mussi, M.; Motta, G.; Agostinelli, C.; Sabattini, E.; Piraccini, B.M.; Pileri, A. A Narrative Review of the State of the Art of CCR4-Based Therapies in Cutaneous T-Cell Lymphomas: Focus on Mogamulizumab and Future Treatments. Antibodies 2024, 13, 32.

6. Therapeutic Advances in Psoriasis: From Biologics to Emerging Oral Small Molecules

银屑病治疗进展：从生物制剂到新兴口服小分子药物

http://www.mdpi.com/2073-4468/13/3/76

Ferrara, F.; Verduci, C.; Laconi, E.; Mangione, A.; Dondi, C.; Del Vecchio, M.; Carlevatti, V.; Zovi, A.; Capuozzo, M.; Langella, R. Therapeutic Advances in Psoriasis: From Biologics to Emerging Oral Small Molecules. Antibodies 2024, 13, 76.

7. Immune-Mediated Necrotizing Myopathy (IMNM): A Story of Antibodies

免疫介导的坏死性肌病（IMNM）：抗体的概述

http://www.mdpi.com/2073-4468/13/1/12

Julien, S.; Challier, I.; Malleter, M.; Jouen, F.; Drouot, L.; Boyer, O. Immune-Mediated Necrotizing Myopathy (IMNM): A Story of Antibodies. Antibodies 2024, 13, 12.

8. SARS-CoV-2: A Glance at the Innate Immune Response Elicited by Infection and Vaccination

SARS-CoV-2：感染和疫苗接种诱导的先天免疫应答概览

http://www.mdpi.com/2073-4468/13/1/13

Manfrini, N.; Notarbartolo, S.; Grifantini, R.; Pesce, E. SARS-CoV-2: A Glance at the Innate Immune Response Elicited by Infection and Vaccination. Antibodies 2024, 13, 13.

9. Ophthalmic Use of Targeted Biologics in the Management of Intraocular Diseases: Current and Emerging Therapies

靶向生物制剂在眼内疾病治疗中的眼科应用：当前和新兴疗法

http://www.mdpi.com/2073-4468/13/4/86

Zong, Y.; Miyagaki, M.; Yang, M.; Zhang, J.; Zou, Y.; Ohno-Matsui, K.; Kamoi, K. Ophthalmic Use of Targeted Biologics in the Management of Intraocular Diseases: Current and Emerging Therapies. Antibodies 2024, 13, 86.

10. A Comparison of Natural and Therapeutic Anti-IgE Antibodies

天然和治疗性抗IgE抗体的比较

http://www.mdpi.com/2073-4468/13/3/58

Vogel, M.; Engeroff, P. A Comparison of Natural and Therapeutic Anti-IgE Antibodies. Antibodies 2024, 13, 58.

Antibodies期刊介绍

主编：Arne Skerra, Technical University of Munich, Germany

期刊主题涵盖抗体和体液免疫反应、抗体的发现、产生和选择、抗体结构和功能、抗体工程、结合物和融合蛋白、生物医学研究和治疗中的抗体。

2025 Impact Factor: 3.3

2025 CiteScore: 4.9

Time to First Decision: 19.5 Days

Acceptance to Publication: 4.9 Days